Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06082453 · ClinicalTrials.gov registry record · NA
Modernizing Perinatal Syphilis Testing
A NA study of Syphilis, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 924
- Enrollment target
- 9
- Study locations
NCT06082453 is a NA study of Syphilis that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 924 participants, above the 120-participant average among 6 other Syphilis trials with a reported enrollment target (670% higher). The trial reports 9 study locations across 4 states.
The verdict
NCT06082453, a NA study of Syphilis, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 924 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to determine the testing performance of real-time quantitative polymerase chain reaction and transcription mediated amplification by comparing test performance of these novel molecular tests to current 2021 CDC CS guidelines for maternal/neonatal dyads at risk for syphilis infection and to determine whether CS is associated with adverse neurodevelopmental outcomes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum
- DIAGNOSTIC_TEST Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum
- OTHER Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis
Study Locations (9)
Texas
- Baylor College of Medicine - Houston
- Texas Children's Hospital - Houston
- The University of Texas Health Science Center at Houston - Houston
- Christus Health - Houston
California
- University of Southern California - Los Angeles
- University of California, Los Angeles - Los Angeles
Maryland
- Johns Hopkins University - Baltimore
- Kennedy Krieger Institute - Baltimore
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 924 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06082453
The ClinicalTrials.gov registry entry for NCT06082453 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 924 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 120-participant average among 6 other Syphilis trials with a reported enrollment target (670% higher). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Syphilis appearing as the primary indexed condition, and to 3 interventions - of which Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum is the first listed.
NCT06082453 reports 9 study locations spanning 4 distinct geographic areas - top geographies include Texas, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT06082453 about?
NCT06082453 is a clinical study titled "Modernizing Perinatal Syphilis Testing". The purpose of this study is to determine the testing performance of real-time quantitative polymerase chain reaction and transcription mediated amplification by comparing test performance of these novel molecular tests to current 2021 CDC CS guidelines for maternal/neonatal dyads at risk for syphil...
What is the current status of trial NCT06082453?
This trial is currently recruiting. It is a NA study. The enrollment target is 924 participants. The study started on 2023-05-02. Estimated completion is 2027-11-30.
What conditions does trial NCT06082453 study?
This clinical trial studies the following conditions: Syphilis.
What interventions are being tested in trial NCT06082453?
The interventions under investigation include: Quantitative polymerase chain reaction (qPCR) assay for detection of Treponema pallidum (DIAGNOSTIC_TEST), Aptima Treponema pallidum transcription-mediated amplification (TMA) assay for detection of Treponema pallidum (DIAGNOSTIC_TEST), Center for Disease Control (CDC) Sexually Transmitted Infections (STI) 2021 Treatment Guidelines for diagnosis of syphilis (OTHER).
Who is sponsoring clinical trial NCT06082453?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06082453 being conducted?
This trial has 9 study locations across California, Maryland, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Syphilis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening
COMPLETED · NA
-
Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission
COMPLETED · NA
-
mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention
COMPLETED · NA
-
Cefixime Clinical Trial
RECRUITING · Phase 3
-
Daily Doxycycline for Early Syphillis
RECRUITING · Phase 2
-
Linezolid for Syphilis Pilot Study
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.